CC

Commodore Capital Portfolio holdings

AUM $1.42B
This Quarter Return
+46.98%
1 Year Return
+73.3%
3 Year Return
+1,330.82%
5 Year Return
10 Year Return
AUM
$184M
AUM Growth
Cap. Flow
+$184M
Cap. Flow %
100%
Top 10 Hldgs %
54.84%
Holding
28
New
28
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 91.66%
2 Financials 1.51%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
CCCC icon
1
C4 Therapeutics
CCCC
$185M
$15.9M 8.67% +481,094 New +$15.9M
TRIL
2
DELISTED
Trillium Therapeutics Inc.
TRIL
$12.5M 6.82% +852,871 New +$12.5M
CNST
3
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$12.2M 6.63% +423,708 New +$12.2M
FPRX
4
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$9.05M 4.92% +532,000 New +$9.05M
KRON
5
DELISTED
Kronos Bio
KRON
$8.93M 4.85% +298,839 New +$8.93M
ISEE
6
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$8.81M 4.79% +1,274,261 New +$8.81M
ACRS icon
7
Aclaris Therapeutics
ACRS
$209M
$8.65M 4.7% +1,336,275 New +$8.65M
COGT icon
8
Cogent Biosciences
COGT
$1.69B
$8.54M 4.64% +760,025 New +$8.54M
CBAY
9
DELISTED
Cymabay Therapeutics
CBAY
$8.53M 4.64% +1,486,107 New +$8.53M
PMVP icon
10
PMV Pharmaceuticals
PMVP
$74.2M
$7.69M 4.18% +125,000 New +$7.69M
SNDX icon
11
Syndax Pharmaceuticals
SNDX
$1.41B
$7.35M 3.99% +330,315 New +$7.35M
XENE icon
12
Xenon Pharmaceuticals
XENE
$2.98B
$7.19M 3.91% +467,368 New +$7.19M
PTGX icon
13
Protagonist Therapeutics
PTGX
$3.67B
$7.01M 3.81% +347,500 New +$7.01M
MREO
14
Mereo BioPharma
MREO
$272M
$6.64M 3.61% +1,854,278 New +$6.64M
CLDX icon
15
Celldex Therapeutics
CLDX
$1.47B
$6.25M 3.4% +356,431 New +$6.25M
VTGN icon
16
VistaGen Therapeutics
VTGN
$102M
$6.11M 3.32% +3,150,000 New +$6.11M
RLMD icon
17
Relmada Therapeutics
RLMD
$37.2M
$5.73M 3.11% +178,565 New +$5.73M
SPRY icon
18
ARS Pharmaceuticals
SPRY
$1.15B
$4.5M 2.45% +97,143 New +$4.5M
KURA icon
19
Kura Oncology
KURA
$686M
$4.36M 2.37% +133,503 New +$4.36M
SURF
20
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$4.32M 2.35% +467,796 New +$4.32M
GNCA
21
DELISTED
Genocea Biosciences, Inc.
GNCA
$4.27M 2.32% +1,765,901 New +$4.27M
MRSN icon
22
Mersana Therapeutics
MRSN
$36.5M
$4.23M 2.3% +158,827 New +$4.23M
IMVT icon
23
Immunovant
IMVT
$2.56B
$3.87M 2.1% +83,782 New +$3.87M
IVA
24
Inventiva
IVA
$861M
$3.35M 1.82% +231,000 New +$3.35M
BLSA
25
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$2.79M 1.51% +250,000 New +$2.79M